These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Introduction to "Optimizing management of non-ST-segment elevation acute coronary syndromes". Harmonizing advances in mechanical and pharmacologic intervention. Boden WE; Pepine CJ J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):1S-6S. PubMed ID: 12644334 [No Abstract] [Full Text] [Related]
7. [Treatment strategy of unstable angina and non-ST-segment elevation myocardial infarction]. Zaliūnas R Medicina (Kaunas); 2002; 38 Suppl 2():11-4. PubMed ID: 12560610 [TBL] [Abstract][Full Text] [Related]
8. Building evidence for early initiation of clopidogrel loading in non-ST-segment elevation acute coronary syndromes: going past the American College of Cardiology/American Heart Association guidelines. Aghababian RV Ann Emerg Med; 2004 May; 43(5):666-8; author reply 668-9. PubMed ID: 15259150 [No Abstract] [Full Text] [Related]
9. Acute coronary syndromes: clearing up controversies in clopidogrel use. Cardiovasc J S Afr; 2006; 17(4):213-4. PubMed ID: 17001429 [No Abstract] [Full Text] [Related]
10. Antiplatelet therapy for ischemic heart disease. Lange RA; Hillis LD N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308 [No Abstract] [Full Text] [Related]
11. [Intervention therapy of acute coronary syndrome]. Yamaguchi T; Nakamura M; Mitsuo K; Matsuda K Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1742-8. PubMed ID: 10581757 [No Abstract] [Full Text] [Related]
12. Drawbacks of nonrandomized trials in acute coronary syndromes. Biondi-Zoccai GG; Abbate A; Agostoni P; Valgimigli M; Sangiorgi GM Am J Cardiol; 2006 Jan; 97(1):151. PubMed ID: 16377303 [No Abstract] [Full Text] [Related]
13. The role of clopidogrel in revascularized and nonrevascularized patients with acute coronary syndromes. Collins JS; Gurm HS Am J Cardiovasc Drugs; 2007; 7(3):159-68. PubMed ID: 17610343 [TBL] [Abstract][Full Text] [Related]
14. [Therapy and physiopathology of acute coronary syndrome]. Yokoyama M Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):548-52. PubMed ID: 9577591 [No Abstract] [Full Text] [Related]
15. [Unstable coronary artery diseases: risk categorization and treatment strategies]. Qian X Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):293-5. PubMed ID: 12947968 [No Abstract] [Full Text] [Related]
17. Management of acute coronary syndromes. Ionescu A; Garg A N Engl J Med; 2005 Dec; 353(25):2714-8; author reply 2714-8; discussion 2714-8. PubMed ID: 16379087 [No Abstract] [Full Text] [Related]
18. [Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure]. Fries R; Böhm M Med Klin (Munich); 2003 Jun; 98(6):326-34. PubMed ID: 12811417 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy with clopidogrel or ticlopidine reduces intimal hyperplasia in an animal model of experimental arterial injury. Kloppenburg G Anadolu Kardiyol Derg; 2010 Feb; 10(1):17. PubMed ID: 20149999 [No Abstract] [Full Text] [Related]